new glp 1 drugs coming What to know about the era of GLP-1 The next generation of GLP-1

The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists (dulaglutide, exenatide, liraglutide, semaglutide and tirzepatide) has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis

Research suggests that foods, such as eggs, vegetables, and olive oil, may help increase GLP-1 levels

Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels

however, they have important limitations in achieving sustainable long-term weight loss

Discover medically supervised weight loss injections and secure telehealth options